We have studied the regulation of arachidonic acid (AA) uptake, metabolism, and release in Aplysia nervous system. Following uptake of [3H]AA, the distribution of radioactivity in intracellular and extracellular lipid pools was measured as a function of time in the presence or absence of exogenous AA. The greatest amount of AA was esterified into phosphatidylinositol (relative to pool size). We found that the intracellular free AA pool underwent rapid turnover, and that radioactive free AA and eicosanoids were released at a rapid rate into the extracellular medium, both in the presence and absence of exogenous AA. Most of the released radioactivity originated from phosphatidylinositol.
Introduction
Arachidonic acid and its metabolites, or eicosanoids, have been implicated in the regulation of a wide variety of biological processes. Some of the best described physiological roles for eicosanoids involve pathological phenomena, such as tissue injury or immune,,~esponses (.I3, 34, 47, 54, 72] . The * Present address: The University of Michigan, Neuroscience ~Building, 1103 East Huron Rd, Ann Arbor, MI 48109. molecular mechanisms that underlie eicosanoid activity in these phenomena are not well defined. However, AA 1 and eicosanoids appear to play a role in the regulation of secretory processes in many tissues. In pancreatic islet cells, eicosanoids have been shown to mediate glucose-induced insulin secretion [43, 57, 70, 74] . In the pituitary and hypothalamus, eicosanoids regulate secretion of many peptide hormones [2, 11, 32, 45, 48, 50, 52] . In certain identified Aplysia neurons, eicosanoids have been implicated in the signal transduction mechanism for the peptide hormone FMFRamide, which activates a potassium current to cause a decrease in transmitter release [55, 56] . This was the first indication that eicosanoids may regulate secretion through modulation of cellular electrical activity.
The concentration of intracellular free AA is kept very low in cells and has been shown to be rate limiting for eicosanoid production [30] . Understanding the regulation of internal free AA, therefore, is crucial for the study of any physiological process involving AA and its metabolites. In this paper, we characterize the regulation of intracellular free AA in Aplysia nervous system. Our interest in Aplysia neural AA metabolism derives from the need for information and tools to help probe for possible AA-mediated modulation of neuronal electrical activity. In the accompanying paper [10] , we exploit the information obtained from the biochemical approaches described here, to investigate the relationship between AA metabolism and electrical activity in identified Aplysia neurons.
i Abbreviations: AA, arachidonic acid; AAext, extracellular free AA; AAi,t, intracellular free AA; AA-CoA, arachidonyl coenzyme A; PL, phospholipid; PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidylserine; PE, phosphatidylethanolamine; NL, neutral lipid; TG, triacylglycerol; TPA, 12-O-tetradecanoylphorbol 13-acetate; BPB, 4-bromophenacylbromide; PLAz, phospholipase Az; PLC, phospholipase C; TLC, thinqayer chromatography.
Materials and Methods

ANIMALS AND REAGENTS
Adult Aplysia californica (100 to 250 g) were supplied by Alacrity Marine Biological Services (Redondo Beach, CA). To anesthetize prior to dissection, Aplysia were injected with up to 100 ml of 0.4 M MgCI2. Ganglia were removed and immediately placed in artificial seawater (ASW, containing in mM: 460 NaC1, 55 MgClz, 11 CaCI2, 10 KCI, 10 NaHEPES, pH 7.3) with 1% (wt/ vol) glucose.
All reagents were of highest grade available. Nonradioactive AA and eicosanoids were purchased from Cayman Chemicals (Ann Arbor, MI). Lipid standards for thin-layer chromatography were from Avanti Polar Lipids (Birmingham, AL) or Sigma. Organic solvents and inorganic salts were from Fisher.
[3H]arachidonic acid (sp act: 191-240 Ci/mmol) was from New England Nuclear (Boston, MA). We found this [3H]AA to be consistently at least 99% pure as determined by TLC. All lipids used in this study were stored under nitrogen at -20 or -70~
LABELING WITH [3H]AA AND RELEASE INCUBATIONS
Pleural and pedal ganglia were used exclusively for results reported in this paper. From each Aplysia, the pleural and pedal pairs were separated with the right and left pleuropedal connectives intact. For simplicity, we refer to this connected pleural and pedal ganglion pair as an individual "pleuropedal" ganglion.
Ganglia were incubated individually for 2-3 hr in ASW containing [3H]AA, and 0.05-0.1% (wt/vol) BSA (fatty acid free, from Sigma or Boehringer Mannheim Biochemicals). Aliquots of [3H]AA were dried under nitrogen, and resolubilized in ethanol prior to solubilization in ASW. The final concentration of ethanol never exceeded 0.5% (vol/vol). To terminate labeling and remove [3H]AA not sequestered intracellularly, ganglia were transferred through two to three changes of fresh ASW without AA.
To assay for release of AA and eicosanoids into the extracellular medium, and to follow distribution of radioactivity as a function of time and different incubation conditions, a labeled pleuropedal ganglion was placed in 1.5 ml of ASW (with 0.1% BSA) kept in constant circulation. This was called "release incubation." During the release incubation, the medium was removed and replaced with fresh medium every 30 min. The medium removed was kept on dry ice for later extraction and analysis of radioactivity in specific lipid pools.
This release incubation procedure was used to test the effects of various treatments on distribution of radioactivity in cellular and released lipids. Stock solutions of BPB (Sigma) were made up fresh in DMSO before experiments. Stock solutions of TPA (Sigma) were stored in single-use aliquots at -20~ The final concentration of carrier DMSO in ASW was usually less than 0.1% (vol/vol), and a matching concentration of DMSO was included in control solutions.
EXTRACTION AND ANALYSIS OF LIPIDS
Extraction
To analyze released radioactivity in more detail, the extracellular medium was extracted for lipid by acidification to pH 3 with R.O. Carlson and I.B. Levitan: Intracellular AA in Aplysia formic acid, followed by extraction with three volumes of ethyl acetate, two or three times. A modified version of the Folch method [23] was used to extract lipid from ganglia. Ganglia were crushed by hand in a Teflon and glass homogenizer containing 0.9 ml of chloroform (CHCI3) : methanol (MeOH) : HC1 (vol/vol/ vol, 1 : 2 : 0.02), and 0.2 ml ASW. This solution was removed, and replaced for a second extraction of the remaining tissue. These two extracts were pooled with 0.4 ml CHCI3 and 0.4 ml H20. After vortexing, the samples were centrifuged to separate the phases. The lower, organic solvent phase, or lipid extract, usually contained 75-80% of the radioactivity originally taken up by the ganglion. (In separate experiments, [3H]AA was found to partition completely into the organic phase under these conditions.)
Thin-Layer Chromatography
Extracellular medium or ganglionic lipid extracts were dried in vacuo using a Savant Speed-Vac. Following removal of solvent, samples were immediately resolubilized in 10-20 /xl CHC13 : MeOH (vol/vol 2 : 1), containing the anti-oxidant butylated hydroxytoluene (100 mg/liter), and stored under nitrogen.
Resolubilized samples were applied in bands to pre-coated silica gel-60 thin layer plates (EM Science). For measuring changes in intracellular free AA, samples were mixed with 0.1/xg nonradioactive AA (for visualization of the AA band with iodine vapor) and were developed in System I:petroleum ether:diethyl ether: acetic acid (vol/vol/vol, 80 : 20 : 1) [46] . For separation of phospholipid, eicosanoids, and neutral lipid, a modification of the one-dimensional, double development system of Heape et al. [25] was used. Phospholipids were resolved with System II : methyl acetate : 1-propanol : CHC13 : MeOH : 0.25% (wt/vol) KC1 (vol/vol/vol/vol/vol, 25 : 25 : 28 : 10 : 7). The plates were air-dried and then redeveloped with System I in the same direction to separate eicosanoids and neutral lipids (phospholipids are immobile in System I). R s values were variable (values from a representative run are given in parentheses in the following sequence), but the mobility sequence was invariant: PC (0.05) < PS (0.11) < PI (0.15) < PE (0.28) < eicosanoids {prostaglandin F2~ (0.5) < prostaglandin E2 (0.56) < 5-hydroxyeicosatetraenoic acid (5-HETE) (0.66) < 15-HETE (0.70)} < AA (0.73) < diooleoylglycerol = triarachidonylglycerol (0.76) < trioleoylglycerol (0.94).
To visualize major phospholipids and neutral lipids, plates were exposed briefly to iodine vapor. For autoradiographic detection of lipids present in small quantities, plates were sprayed with En3hance (New England Nuclear), wrapped in plastic wrap, and used to expose Kodak X-ray omat-R-film with aid of enhancing screens. Iodine-visualized or autoradiographic bands were used as guides for scraping plates to assay radioactivity present in individual lipid pools. Plate scrapings were suspended in 3 ml of Beckman Ready-Solv HP/b scintillation fluid for liquid scintillation counting in a Beckman LS6800 scintillation counter.
Lipid Phosphate
Lipid phosphate was assayed by first digesting lipid extracts or scrapings from thin-layer plates in 0.25 ml 10 N I-I2SO 4 for 3 hr at 160-180~ in acid washed tubes, as described by Keenan et al [33] . The subsequent steps were modified after Sanui [63] . After cooling, 1.8 ml water, 3.0 ml butyl acetate, and 0.9 ml 2.25% ammonium molybdate were added sequentially, and the tubes were capped and vortexed for 30 sec. Absorbance of the upper, butyl acetate phase was measured at 311 urn. Standard curves were generated from samples containing 25-100 nmol inorganic phosphate.
STATISTICS
Unless otherwise stated, error bars in graphs represent the standard deviation of independent measurements from at least three ganglia. Where indicated in parentheses, the number of observations refer to the number of individual ganglia used for a particular experiment. Student's t test was used to test for significant differences under different experimental conditions.
Results
AA METABOLISM IN Aplysia NERVOUS SYSTEM
Uptake Figure 1 depicts a simplified mechanism of AA metabolism derived from studies of fatty acid uptake [15, 16, 67] and metabolism [61] . AA initially enters cells by nonenzymic partitioning into membrane lipid (pathway labeled I in Fig. 1 ). Acyl-CoA synthetases convert AA in the membrane to arachidonyl-coenzyme A esters (AA-CoA), the activated form of AA required for esterification into lipid (H). Acyl-CoA transferases catalyze condensation of AA-CoA with lysophospholipid to produce phospholipid (IV), or with diacylglycerol to produce triacylglycerol (III). Once in storage, hydrolysis of AA from phospholipid is the primary source of internal free AA (V). Several classes of enzymes, including cyclooxygenase, lipoxygenases, and epoxygenases, catalyze conversion of internal free AA to eicosanoids (VII).
To characterize the details of AA metabolism specific to Aplysia nervous system, we studied up- The Table lists the distribution of radioactivity in major lipid pools from ganglia labeled under similar conditions. In this and other experiments that involved labeling, total uptake of radioactivity was used to normalize for differences in amount of ganglionic tissue. We routinely express the content of radioactivity in AA-containing pools as "percent of total [3H]AA uptake." For the normal labeling protocol, -5 • 106 dpm were taken up into a single pleuropedal ganglion. Less than 1% of the total AA taken up (-50,000 dpm) was found as internal, free, unmetabolized AA. The majority of the AA taken up was esterified into either phospholipid or neutral lipid. Production of eicosanoids was detected by the appearance of bands of radioactivity which migrated in thin-layer chromatography with several authentic eicosanoids. This putative eicosanoid radioactivity was only detectable in the extracellular medium (autoradiographs of thin-layer chromatographs of intracellutar lipids never contained distinct bands of radioactivity in the region of eicosanoid mobility), as could be predicted from the general observation that cells do not store eicosanoids [30] . These bands of putative eicosanoids were not due to autooxidation of AA. Six hours of incubation of [3H]AA alone in ASW at room temp. did not produce bands of radioactivity which ran in the defined region of eicosanoid mobility. The Table also lists the relative prevalence of individual phospholipids as measured by lipid phosphate content. Over half of the measured lipid phosphate was found in PC. Most of the remaining phosphate was found in PI, PS, and PE (in order of measured content). The ratio of AA uptake to lipid phosphate provides a measure of the amount of AA taken up relative to the phospholipid pool size. Based upon this ratio, two to three times as much radioactivity was esterified into PI, relative to the PI pool size, as compared to other phospholipids.
AA uptake into ganglionic lipids was measured as a function of time. The partitioning of AA into specific pools was measured in 0.6 and 50/XM AA. The percentage of AA found free or esterified into phospholipid or neutral lipid did not vary from 30 min to 4 hr of incubation in 0.6/ZM. Except for an increase in radioactivity in triacylglycerol and a concomitant decrease in radioactivity in an unidentified neutral lipid which ran at the solvent front, this lack of time dependence for the distribution of radioactivity was observed for all other lipids extracted from ganglia incubated 10 min to 2 hr in 50 /~M AA. We also assayed uptake of AA as a function of exogenous AA concentration. Esterification of AA into phospholipids began to approach saturation above 0.6/~M exogenous AA (depicted in Fig. 2A for PC, PI, and PS from ganglia incubated in 60 ng to 25 /ZM AA). Esterification into triacylglycerol continued to increase up to 25 /*M AA (Fig. 2B ). This lack of saturation is in agreement with the nearly unlimited capacity of cells in culture for fatty acid uptake into triacylglycerol, which accumulates as liposomes in th e cytoplasm of cells to the point of rupture [61] . Triacylglycerol was the main neutral lipid for AA storage. In 60 nM AA, 74% of the radioactivity found in neutral lipid was in triacylglycerol, increasing to 95% in 25/*M AA. At the lowest concentrations tested (60-200 riM), uptake into phospholipid was two-to threefold greater than uptake into triacylglycerol; conversely, in 50/zM AA, over five times as much AA was esterified into triacylglycerol. Accumulation of AA in the internal free AA pool did not saturate in up to 25/,M AA (Fig. 2C) . Therefore, at higher exogenous AA concentrations, flux into the free AA pool likely is coupled to the uptake from this pool into triacylglycerol.
Release into Extracellular Medium
Radioactivity was released from labeled ganglia into release incubation medium (ASW with 1% (wt/vol) glucose and 0.1% (wt/vol) fatty acid free BSA) at a constant rate. The presence of BSA was not required to observe release of radioactivity, but adding BSA at 1 mg/ml increased basal release about twofold. BSA was routinely included to act as a trap for lipids released from ganglia. 83 +-8% (n = 35) of released radioactivity was contained in free AA (29%) and eicosanoids (54%); the remaining radioactivity ran in the region of neutral lipid mobility. This distribution of released radioactivity did not vary with time. Figure 3 shows a comparison of radioactivity in free AA released into the extracellular medium with radioactivity in intracellular free AA as a function of time. Internal free AA was defined as free AA radioactivity present in the extract of cellular lipids which was not removed previously by multiple washes of an intact ganglion with fresh medium. Radioactivity in released free AA increased steadily with time of incubation, while the amount of internal free AA radioactivity remained constant. There is no precedence for extracellular release of free AA from cellular lipid without the liberated AA first passing through an intracellular free pool. Therefore, constant release of free AA demonstrates that at least a portion of the internal free AA pool was constantly turning over.
Uptake and Release of AA from Sheath and Neurons
After freezing in dry-ice cooled 80% ethylene glycol in ASW, labeled ganglia were dissected into neural and sheath components. The sheath was found to contain an average of 92% (n = 6) of the radioactivity taken up by the whole ganglion. The sheath also contained about 95% of the whole ganglion lipid phosphate. Therefore, when normalized to phospholipid content, uptake of [3H]AA into the sheath and neural components was about equal. Furthermore, we observed no differences between the two components in distribution of radioactivity in storage lipids, which was similar to the average distri- Table. However, the neural component was found to release AA and eicosanoids at nearly 10 times the rate of release from the sheath. Sheath and neural components were dissected apart in fresh, labeled ganglia, and the components were incubated separately in release incubation medium. After 15 min, the medium of the neural component contained AA and eicosanoids at 7.0 and 10.6% (respectively) of the total radioactivity of neural component lipid. Over the same time period, the incubation medium of the sheath contained only 0.9 and 1.3% of the total radioactivity of sheath lipid in AA and eicosanoids.
Pulse-Chase
A pulse-chase protocol was used to further probe AA metabolism in Aplysia nervous system. Ganglia were "pulse"-labeled and then incubated with no exogenous AA (similar to Fig. 3 ) or with a chase of 50 ~M nonradioactive AA for 2 to 6 hr. Figure 4 shows the changes in relative content of radioactivitY: :in individual lipid pools following incubation witli this nonradioactive exogenous AA. Only phospholipid lost radioactivity in the presence of exogenous AA. The loss from PI was the greatest, and was the only substantial loss observed with both 2 TPA, also increased release of AA and eicosanoids from ganglia. In 500 nM TPA, external release was stimulated on average fivefold, largely due to an increase in release of free AA (Fig. 5) . Radioactivity in internal free AA, and putative eicosanoids released into the medium, both increased about twofold (Fig. 5 ), in agreement with the general finding that the availability of intracellular AA is limiting for eicosanoid production [30] . The effect of TPA was dose dependent, with half-maximal stimulation at 15 nM, and saturation above 100 nM (Fig. 6 ). This dose dependence is consistent with TPA acting through protein kinase C to stimulate liberation of AA from storage. Also, the lack of effect of the phorbol ester, 4-a-phorbol (at 1/a,M, see Fig. 6 ), which does not activate PKC in vitro, is consistent with involvement of PKC in the observed stimulation [12] .
A loss of radioactivity from phospholipid, specifically PI and PC, accompanied the TPA-stimulated efflux of AA and eicosanoids into the extracellular medium. This change in distribution of radioactivity could have resulted from an inhibition of AA esterification into phospholipid, or stimulation of liberation from phospholipid. We tested the effect of TPA under the pulse-chase paradigm to distinguish between these possibilities. If TPA inhibited esterification into phospholipid, then TPA should have had less effect in the presence of a concentration of exogenous AA that saturated uptake into phospholipid (see Fig. 2 ). Figure 7 shows TPA still had a profound effect under these conditions, increasing loss of radioactivity from phospholipid, efflux of radioactive free AA and eicosanoids, and accumulation of radioactivity in neutral lipid relative to chase alone. Also, the internal free AA radioactivity increased nearly twofold, with a commensurate increase in radioactivity in eicosanoids. The effects of both TPA and depolarizing agents were strictly dependent on extracellular calcium, suggesting at least a partially shared mechanism of activation. Substitution of calcium in the extracellular medium with 20 mM cobalt, a blocker of voltage-dependent calcium channels, completely suppressed the response to depolarizing agents or TPA. Also, lowering calcium in the medium from 11 mM to 100 /xM was sufficient to block the effect of TPA. Raising extracellular calcium to 60 mM increased TPA-induced stimulation about twofold. Although lowering calcium in the medium did not affect basal release of radioactivity, raising bath calcium to 50 mM increased basal release from 4.3% of uptake/hr to 10.5%/hr. 4-bromophenacylbromide is established as an irreversible inactivator of phospholipase A2 [58, 71] . Figure 8 depicts the effect of 50/~M BPB in the presence of 50 txM exogenous AA chase. The chase-induced loss of radioactivity from PI and increase in radioactivity in triacylglycerol and free AA in the medium were completely inhibited in the presence of BPB. Also, in the presence of exogenous AA and BPB, radioactivity in internal free AA was 48 -+ 13% (n = 7) less than in exogenous AA alone. These results are consistent with inhibition of phospholipase by BPB.
Discussion
FREE AA BUFFERING
Uptake of radioactivity into the internal free AA pool did not saturate in up to 25 ~M exogenous AA.
This demonstrated a large flux of exogenous AA into the internal AA pool was occurring in the presence of 25 /ZM AA. If the size of the internal free pool was significantly increased due to this influx of exogenous AA, the resulting decrease in the specific activity should have been detected as a decrease in radioactivity in AA and eicosanoids released into the extracellular medium. The substantial increase in release of radioactive free AA, and lack of change (or a very slight increase) in release of radioactive eicosanoids during the chase, suggests 50/xM exogenous AA did not significantly change the size of the internal free AA pool or the resting level of eicosanoid production. In other words, the AA that is taken up must be converted immediately to some other form, likely AA-CoA, which makes the AA unavailable for conversion to eicosanoids. This result is critical, because it suggests application of exogenous AA may not be an effective means of increasing eicosanoid production for investigation of eicosanoid-mediated physiology. If exogenous AA does not change the internal free AA pool size or eicosanoid production, acute physiological effects observed with the use of exogenous AA cannot be a result of increased eicosanoid production, but most likely result from direct actions of AA, acting at external receptors, or from altered AA content in glycerolipids. We plan to test this interpretation of our pulse-chase data by gasliquid chromatographic measurement of free AA concentration and radioimmunoassay for specific eicosanoids.
If this interpretation is correct, pathways responsible for esterification of AA into lipid must buffer internal AA efficiently enough to prevent a significant increase in internal free AA in the presence of high external AA. Acyl-CoA synthetase activity (Fig. 1, pathway I/) is a good candidate for rapid sequestration of free AA in the presence of an exogenous source. An acyl-CoA synthetase which favors 20 carbon unsaturated fatty acids as substrates was isolated from platelets in an effort to understand how the level of free AA is maintained so low relative to other fatty acids [49, 73] . This arachidonyl-CoA synthetase exhibited nanomolar affinity for AA, the highest affinity among the fatty acids tested, and had a very high turnover rate. Since this first demonstration, arachidonyl-CoA synthetase activity has been measured in many tissues [36] , and, although untested, Aplysia nervous system may also contain this activity.
If the size of the internal free AA pool does not change significantly in the presence of a high concentration of exogenous AA, how can we explain the different characteristics of uptake into storage lipids as a function of AA concentration? If synthetase activity rapidly converts AA to AA-CoA, the AA-CoA concentration likely increases with increasing exogenous AA. Intracellular accumulation of exogenous tong chain fatty acids as CoA-esters has been shown to inhibit B-oxidation of other fatty acids, due to sequestration of acetyl-CoA [3, 53] . If the size of the AA-CoA pool increases with increasing exogenous AA, the results of the uptake experiments could be interpreted to reflect the different affinities of fatty acyl-CoA transferases for AACoA. Transferases for esterification into phospholipid may have high affinity for AA-CoA, but saturate at a relatively low concentration; the diglyceride acyltransferases may have somewhat lower affinity, but may not reach saturation for the concentration of AA-CoA produced in up to 50 b~M AA. The combination of a high affinity synthetase with rapid turnover, and two transferases with affinities for AA-CoA covering a broad range of AA-CoA concentration, could provide an efficient buffering system for free AA.
PHOSPHOLIPASE ACTIVITY
The phospholipase activity responsible for liberation of AA from phospholipid could involve PLA2 or phospholipase C. Direct hydrolytic removal of AA by PLA2, or indirect liberation through the activity of PLC on phosphoinositides to produce diacylglycerol which is broken down into monoacylglycerol and AA, are the primary mechanisms for liberation of AA from phospholipid. Which of these is the most important remains in dispute [30, 34, 61] . BPB is an irreversible inhibitor of purified PLA2 in vitro [58, 71] , and BPB has been shown to inhibit PLA2 (as indicated by inhibition of AA release from phospholipid) in vivo, in a variety of tissues [1, 8, 29, 31, 65] , and in an irreversible manner [9, 42] . In Aplysia ganglia, BPB inhibited the effect of chase, and decreased internal free AA, suggesting involvement of PLA2 in basal liberation of AA from phospholipid. However, this effect of BPB is not sufficient to conclude PLA2 is the most important pathway for liberation of AA in Aplysia.
The calcium dependence of TPA-or depolarization-induced stimulation of AA liberation suggests the involvements of PLA2. Purified PLA2 is strictly dependent on added calcium, and several isoforms purified from sheep platelets respond to changes in free calcium in the micromolar range [38] , suggesting the potential for calcium-mediated activation of PLA2 within a physiological range of calcium concentrations. In contrast, PLC functions optimally with resting levels of free calcium; therefore, increasing intraceltular calcium generally does not activate PLC [6, 44] ,
The specific phospholipid source of AA varies between tissues. PC and PE are commonly involved; however, specific loss of AA from PI has been reported. PI is the primary source of stimulated AA liberation in platelets [73] . In a glioma cell line, acetylcholine stimulated specific loss of AA from PI in a mechanism involving initial activation of PLC, leading to calcium-mediated PLA2 stimulation and breakdown of PI to AA and lysophosphatidylinositol [14] . Parallel stimulation of PLC and PLA2 in canine kidney cells has been shown to occur with al-adrenoceptor activation, leading to liberation of AA from PI [66] . Specific PLA2-catalyzed liberation of AA from PI has also been demonstrated in mouse macrophages [20, 21] . The latter studies are among many examples of phorbol esterstimulated liberation of AA from phospholipid, believed to result from PLA2 activation [24, 26, 27, 511.
Both BPB and TPA affected AA metabolism in Aplysia, likely through modulation of phospholipase activity. TPA was tested in the pulse-chase experiments to determine if TPA-stimulated AA turnover was due to inactivation of phospholipase or inhibition of enzymes catalyzing esterification. TPA was still very effective with chase; therefore, TPA must stimulate phospholipase activity in Aplysia. This is consistent with the possibility phospholipase activity is rate limiting for turnover of AA, as has been observed in other systems [28, 30] . If phospholipase activity is not at least partially rate limiting, activation or inhibition of this activity (by TPA and BPB, respectively) would not have had such a pronounced effect. Also, in a preliminary experiment, we found BPB inhibited uptake of AA into phospholipid about 50% (data not shown).
Therefore, we conclude phospholipase activity is probably rate limiting for turnover of free AA in Aplysia ganglia.
PROTEIN KINASE C
The dose dependence of TPA stimulation suggests participation of protein kinase C in the phospholipase activation mechanism. However, we do not know whether protein kinase C directly activates phospholipase through phosphorylation of the enzyme. Phorbol esters have been shown to increase voltage-dependent calcium currents in two different neuronal cell types in Aplysia, the bag cell neurons of the abdominal ganglion [17] , and the sensory neurons of the pleural ganglion [7] ; this might occur in other neurons as well. Therefore, TPA-mediated activation of protein kinase C could cause an increase in intracellular calcium which would then stimulate phospholipase activity. A similar mechanism may account for depolarization-induced release of AA and eicosanoids. However, in vitro depolarization is an inefficient means for loading cells with calcium, because a sustained increase in intracellular calcium will rapidly inactivate calcium channels [19] . Depolarization may prove a more potent stimulator of AA turnover if studied with electrically-induced depolarizations of physiological duration.
UPTAKE AND METABOLISM BY SHEATH
Although almost all of the radioactivity taken up into whole ganglia was sequestered by the sheath, the use of whole ganglia in this study does not detract from the results. First, the ganglionic sheath of Aplysia and many other molluscs is known to contain many neuritic processes [4, 5, 18, 37, 59, 62] . The similarity between the rate of AA uptake and distribution of radioactivity in storage lipids, and distribution of radioactivity in released AA and eicosanoids in neural and sheath components, suggest the neuritic processes present in the sheath may be largely responsible for the observed AA metabolism. Second, we have found that exogenous AA is sequestered avidly by isolated clusters of cell bodies and Aplysia neurons in primary culture, and we also found that TPA stimulated release of radioactivity from the labeled clusters of cell bodies (data not shown). Third, the prodigious rate of release of AA and eicosanoids from the isolated neural component suggests the magnitude of the results reported in this paper would only be larger if this work were repeated with isolated cell bodies. Finally, the regulation of AA metabolism is known to involve intercellular, or paracrine interactions, as has been shown for interactions between platelets, white blood cells, and endothelium [35, 39, 40, 41, 64] . Therefore, the study of AA metabolism on the level of the whole ganglia is most meaningful for eventual in vivo extrapolation of these results.
SECRETION OF AA AND EICOSANOIDS
A substantial rate of intracellular AA turnover has been observed in many types of cells in culture [67] . Also, constant release of radioactive free fatty acids with lack of concomitant change in internal free fatty acid radioactivity has been observed in bovine aortic endothelial cells in culture [22] . However, we are not aware of a report of constant release of eicosanoids at rest. Based upon the finding that depolarization stimulated eicosanoid production in Aplysia, it is possible spontaneous neural activity may account for this "resting" eicosanoid production. The total release of radioactive free AA and eicosanoids averaged -2% of total uptake per hour of release incubation. If futile, this constant loss of AA by secretion or conversion to eicosanoids must be expensive for the cell to maintain. Also, eicosanoids have multiple biological activities and are typically active at very low concentrations. A random, futile production of eicosanoids would likely have undesirable physiological effects. We conclude that this considerable and constant net loss of AA and eicosanoids may not be the result of futile cycling, but rather it is more likely the by-product of a rapid deacylation-reacylation cycle which regulates intracellular free AA tightly. In the accompanying paper [I0], we investigate the possibility that this constant cycling or turnover has a role in regulation of electrical activity in Aplysia nervous system. This work was supported by NIH grant NS17910 to I. B. L. We are grateful to David Wilson for his critical comments on the manuscript.
